Advances in ophthalmology practice and research最新文献

筛选
英文 中文
Integration of smartphone technology and artificial intelligence for advanced ophthalmic care: A systematic review 将智能手机技术与人工智能整合用于高级眼科护理:系统回顾
Advances in ophthalmology practice and research Pub Date : 2024-08-01 Epub Date: 2024-03-25 DOI: 10.1016/j.aopr.2024.03.003
Kai Jin , Yingyu Li , Hongkang Wu , Yih Chung Tham , Victor Koh , Yitian Zhao , Ryo Kawasaki , Andrzej Grzybowski , Juan Ye
{"title":"Integration of smartphone technology and artificial intelligence for advanced ophthalmic care: A systematic review","authors":"Kai Jin ,&nbsp;Yingyu Li ,&nbsp;Hongkang Wu ,&nbsp;Yih Chung Tham ,&nbsp;Victor Koh ,&nbsp;Yitian Zhao ,&nbsp;Ryo Kawasaki ,&nbsp;Andrzej Grzybowski ,&nbsp;Juan Ye","doi":"10.1016/j.aopr.2024.03.003","DOIUrl":"10.1016/j.aopr.2024.03.003","url":null,"abstract":"<div><h3>Background</h3><p>The convergence of smartphone technology and artificial intelligence (AI) has revolutionized the landscape of ophthalmic care, offering unprecedented opportunities for diagnosis, monitoring, and management of ocular conditions. Nevertheless, there is a lack of systematic studies on discussing the integration of smartphone and AI in this field.</p></div><div><h3>Main text</h3><p>This review includes 52 studies, and explores the integration of smartphones and AI in ophthalmology, delineating its collective impact on screening methodologies, disease detection, telemedicine initiatives, and patient management. The collective findings from the curated studies indicate promising performance of the smartphone-based AI screening for various ocular diseases which encompass major retinal diseases, glaucoma, cataract, visual impairment in children and ocular surface diseases. Moreover, the utilization of smartphone-based imaging modalities, coupled with AI algorithms, is able to provide timely, efficient and cost-effective screening for ocular pathologies. This modality can also facilitate patient self-monitoring, remote patient monitoring and enhancing accessibility to eye care services, particularly in underserved regions. Challenges involving data privacy, algorithm validation, regulatory frameworks and issues of trust are still need to be addressed. Furthermore, evaluation on real-world implementation is imperative as well, and real-world prospective studies are currently lacking.</p></div><div><h3>Conclusions</h3><p>Smartphone ocular imaging merged with AI enables earlier, precise diagnoses, personalized treatments, and enhanced service accessibility in eye care. Collaboration is crucial to navigate ethical and data security challenges while responsibly leveraging these innovations, promising a potential revolution in care access and global eye health equity.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 3","pages":"Pages 120-127"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000210/pdfft?md5=15dd74fd99010c9b70eb60504d51094d&pid=1-s2.0-S2667376224000210-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140407776","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Personalized treatment approaches in intraocular cancer 眼内癌的个性化治疗方法
Advances in ophthalmology practice and research Pub Date : 2024-08-01 Epub Date: 2024-04-13 DOI: 10.1016/j.aopr.2024.03.005
Yating Liu , Alexander C. Rokohl , Yongwei Guo , Ke Yao , Wanlin Fan , Ludwig M. Heindl
{"title":"Personalized treatment approaches in intraocular cancer","authors":"Yating Liu ,&nbsp;Alexander C. Rokohl ,&nbsp;Yongwei Guo ,&nbsp;Ke Yao ,&nbsp;Wanlin Fan ,&nbsp;Ludwig M. Heindl","doi":"10.1016/j.aopr.2024.03.005","DOIUrl":"10.1016/j.aopr.2024.03.005","url":null,"abstract":"<div><h3>Background</h3><p>Intraocular malignant tumors represent a severe disease that threatens vision as well as life. To better extend the life of the patient, preserve visual function, and maintain ocular aesthetics, selecting the appropriate timing and methods of treatment becomes crucial.</p></div><div><h3>Main text</h3><p>With the continuous advancement of medical technology, the techniques and methods for treating intraocular malignant tumors are constantly evolving. While surgery was once considered the optimal method to prolong patient survival and prevent local recurrence, the discovery and application of various treatments such as radiotherapy, laser therapy, chemotherapy, cryotherapy, and monoclonal antibodies have led to a greater diversity of treatment options. This diversity offers more possibilities to develop personalized treatment plans, and thereby maximize patient benefit. This article reviews the various treatment methods for intraocular malignant tumors, including indications for treatment, outcomes, and potential complications.</p></div><div><h3>Conclusions</h3><p>Differentiating small intraocular malignant tumors from pigmented lesions is challenging, and ongoing monitoring with regular follow-up is required. Small to medium-sized tumors can be treated with radiotherapy combined with transpupillary thermotherapy. Depending on the tumor's distance from the optic disc, surgery with partial resection may be considered for distant tumors, while proximal tumors may require complete enucleation. Systemic chemotherapy has been widely applied to patients with retinal tumors, lymphomas, and intraocular metastatic cancers, but has limited efficacy in patients with choroidal melanoma. Antagonists of Vascular Endothelial Growth Factor (Anti-VEGF) drugs can improve patient vision and quality of life, while the efficacy of immunotherapy and molecular targeted therapy is still under research.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 3","pages":"Pages 112-119"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000234/pdfft?md5=cd20b9dbf34570c7951965f15ad080e8&pid=1-s2.0-S2667376224000234-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140790633","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Global incidence and prevalence of malignant orbital tumors 全球恶性眼眶肿瘤的发病率和流行率
Advances in ophthalmology practice and research Pub Date : 2024-08-01 Epub Date: 2024-04-13 DOI: 10.1016/j.aopr.2024.04.002
Weina Zhang , Alexander C. Rokohl , Yongwei Guo , Ke Yao , Wanlin Fan , Ludwig M. Heindl
{"title":"Global incidence and prevalence of malignant orbital tumors","authors":"Weina Zhang ,&nbsp;Alexander C. Rokohl ,&nbsp;Yongwei Guo ,&nbsp;Ke Yao ,&nbsp;Wanlin Fan ,&nbsp;Ludwig M. Heindl","doi":"10.1016/j.aopr.2024.04.002","DOIUrl":"10.1016/j.aopr.2024.04.002","url":null,"abstract":"<div><h3>Purpose</h3><p>Aims to provide an overview of the contemporary epidemiology of malignant orbital tumors by analyzing population-based incidence patterns across various regions worldwide.</p></div><div><h3>Methods</h3><p>In this article, we retrieved orbital malignancy data from the MEDLINE database and analyzed the incidence and prevalence of orbital malignancies worldwide. We performed the literature search by searching on the Mesh terms for malignant orbital tumors (\"orbital\", \"tumor\", \"lymphoma\", \"malignant\", \"cancer\", \"incidence\", and \"epidemiology\"). All included studies were published between 1993 and 2023 and were written in English.</p></div><div><h3>Results</h3><p>Ocular or ophthalmic lymphoma most frequently occurred in the orbit, with a prevalence ranging from 47% to 54%. The incidence of malignant orbital tumors was increasing in the USA (2.0 per million (1981–1993), Netherlands (0.86 (1981–1985) to 2.49 (2001–2005) per million) and South Korea (0.3–0.8 per million (1999–2016)), respectively. Ophthalmic lymphoma which includes orbit lymphoma was increasing in Canada (0.17–1.47 per million (1992–2010)), Denmark (0.86 per million (1981–1985) to 2.49 per million (2001–2005)), respectively.</p></div><div><h3>Conclusions</h3><p>The predominant primary malignant orbital tumor in adults was lymphoma. Ocular or ophthalmic lymphoma most frequently occured in the orbit. The limited data available suggested an increasing trend in the incidence of malignant orbital tumors in each country included, which were mainly attributed to the increase in lymphoma. Generally, incidence rates were found to increase with advancing age, with no difference between males and females.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 3","pages":"Pages 128-133"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000258/pdfft?md5=a9b2f717d8d47403acbe608cea43c19a&pid=1-s2.0-S2667376224000258-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140796202","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation and application of a Chinese version symptom questionnaire for visual dysfunctions (CSQVD) in school-age children 中文版学龄儿童视觉功能障碍症状问卷(CSQVD)的评估与应用
Advances in ophthalmology practice and research Pub Date : 2024-08-01 Epub Date: 2024-05-11 DOI: 10.1016/j.aopr.2024.05.001
Fuyao Chen, Lixia Lou, Xiaoning Yu, Peike Hu, Weiyi Pan, Xuan Zhang, Xiajing Tang
{"title":"Evaluation and application of a Chinese version symptom questionnaire for visual dysfunctions (CSQVD) in school-age children","authors":"Fuyao Chen,&nbsp;Lixia Lou,&nbsp;Xiaoning Yu,&nbsp;Peike Hu,&nbsp;Weiyi Pan,&nbsp;Xuan Zhang,&nbsp;Xiajing Tang","doi":"10.1016/j.aopr.2024.05.001","DOIUrl":"10.1016/j.aopr.2024.05.001","url":null,"abstract":"<div><h3>Objective</h3><p>To develop and evaluate a Chinese version of the Symptom Questionnaire for Visual Dysfunctions (CSQVD) to quantify visual dysfunction symptoms in school-age children with various eye diseases, and to explore the relationship between ophthalmological disorders and visual dysfunction symptoms.</p></div><div><h3>Methods</h3><p>Following standard scale adaptation procedures, the Symptom Questionnaire for Visual Dysfunctions (SQVD) was translated into Chinese (CSQVD). We employed random sampling to survey 198 outpatients aged 7–18 to assess the psychometric properties of the CSQVD. Using the reliable and validated questionnaire, we evaluated the determinants of visual dysfunction symptoms among 406 school-age patients at an eye center. The CSQVD scores were correlated with demographic and clinical variables, including gender, age, eye position, refractive power, and best-corrected visual acuity. Univariate analysis identified potential risk factors, followed by binary logistic regression and multiple linear regression analysis on factors with a <em>P</em>-value &lt;0.05.</p></div><div><h3>Results</h3><p>The CSQVD scale's critical ratio (CR) values ranged from 6.028 to 10.604. The Cronbach's Alpha coefficient was 0.779, and Spearman-Brown split-half reliability was also 0.779. The I-CVI varied from 0.83 to 1.000, the S-CVI/Ave was 0.857, and the KMO value was 0.821. Multifactorial regression analysis indicated that high myopia (OR ​= ​5.744, 95% CI [1.632, 20.218], <em>P</em> ​= ​0.006) and amblyopia (OR ​= ​9.302, 95% CI [1.878, 46.058], <em>P</em> ​= ​0.006) were significant predictors of CSQVD symptoms. Multiple linear regression analysis showed that BCVA of amblyopic eyes (B ​= ​−5.052, 95% CI [−7.779, 2.325], <em>P</em> ​= ​0.000) and SE power (B ​= ​−0.234, 95% CI [−0.375, 0.205], <em>P</em> ​= ​0.001) significantly affected the CSQVD scale scores.</p></div><div><h3>Conclusions</h3><p>The Chinese version of the SQVD scale (CSQVD) demonstrates good feasibility, discriminatory power, validity, and reliability in assessing Chinese school-aged children. Furthermore, those who have severe myopia and amblyopia reported more visual dysfunction symptoms.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 3","pages":"Pages 134-141"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000349/pdfft?md5=f440aa6d6704f56cc87889e678d7b3dd&pid=1-s2.0-S2667376224000349-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141031474","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TOC 技术选择委员会
Advances in ophthalmology practice and research Pub Date : 2024-08-01 Epub Date: 2024-08-13 DOI: 10.1016/S2667-3762(24)00045-3
{"title":"TOC","authors":"","doi":"10.1016/S2667-3762(24)00045-3","DOIUrl":"10.1016/S2667-3762(24)00045-3","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 3","pages":"Pages iii-iv"},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000453/pdfft?md5=fb90564753531009a4d918164ac6cb5b&pid=1-s2.0-S2667376224000453-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141979408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A UV-related risk analysis in ophthalmic malignancies: Increased UV exposure may cause ocular malignancies 眼科恶性肿瘤中紫外线相关风险分析:紫外线照射增加可能导致眼部恶性肿瘤
Advances in ophthalmology practice and research Pub Date : 2024-05-01 Epub Date: 2024-04-05 DOI: 10.1016/j.aopr.2024.04.001
Xiaojun Ju , Alexander C. Rokohl , Xueting Li , Yongwei Guo , Ke Yao , Wanlin Fan , Ludwig M. Heindl
{"title":"A UV-related risk analysis in ophthalmic malignancies: Increased UV exposure may cause ocular malignancies","authors":"Xiaojun Ju ,&nbsp;Alexander C. Rokohl ,&nbsp;Xueting Li ,&nbsp;Yongwei Guo ,&nbsp;Ke Yao ,&nbsp;Wanlin Fan ,&nbsp;Ludwig M. Heindl","doi":"10.1016/j.aopr.2024.04.001","DOIUrl":"https://doi.org/10.1016/j.aopr.2024.04.001","url":null,"abstract":"<div><h3>Purpose</h3><p>To explore the role of ultraviolet radiation (UVR) in the occurrence and development of various ocular malignancies.</p></div><div><h3>Methods</h3><p>In this article, we retrieved ocular malignancy data from the Global Cancer Observatory (GCO) and performed correlation analysis with the global UV index and sunshine duration. We searched for associated studies using the following databases: Embase, Pubmed, Cochrane Library, and Google Scholar. We conducted the literature by searching the Mesh terms denoting an exposure of interest (\"UV radiation\", \"ultraviolet rays\", and \"ocular malignancies\", All studies included are published until December 30, 2023 without language restrictions.</p></div><div><h3>Results</h3><p>The mechanisms and epidemiological statistics of UVR on the onset and progression of eyelid malignancies are the most studied and clear. The role of UVR in conjunctival melanoma is similar to that in eyelid melanoma. The relationship between uveal melanoma and UVR is controversial, however, it may have at least a certain impact on its prognosis. UVR causes ocular surface squamous neoplasia by further activating HPV infection.</p></div><div><h3>Conclusions</h3><p>UVR is a decisive risk factor for ocular malignancies, but the incidence of ultraviolet-induced tumors is also affected by many other factors. A correct and comprehensive understanding of the mechanisms of UVR in the pathogenesis of ocular malignant tumors can provide patients with more effective and selective immune regulation strategies.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 2","pages":"Pages 98-105"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000246/pdfft?md5=39c7b132d984605dc2a43b0ddb236370&pid=1-s2.0-S2667376224000246-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140650903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye 3% 地卡夫索联合盐酸阿司匹林对过敏性结膜炎干眼症患者的疗效
Advances in ophthalmology practice and research Pub Date : 2024-05-01 Epub Date: 2024-02-10 DOI: 10.1016/j.aopr.2024.01.006
Lin Lin , Yirui Zhu , Kelan Yuan, Yujie Mou, Hanhe Zhao, Yayin Wu, Xiuming Jin
{"title":"Efficacy of 3% diquafosol combined with azelastine hydrochloride in allergic conjunctivitis patients with dry eye","authors":"Lin Lin ,&nbsp;Yirui Zhu ,&nbsp;Kelan Yuan,&nbsp;Yujie Mou,&nbsp;Hanhe Zhao,&nbsp;Yayin Wu,&nbsp;Xiuming Jin","doi":"10.1016/j.aopr.2024.01.006","DOIUrl":"10.1016/j.aopr.2024.01.006","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 2","pages":"Pages 47-51"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000064/pdfft?md5=789942a866e56ed7a429a4450875c3fb&pid=1-s2.0-S2667376224000064-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139824158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges 利用干细胞再生治疗眼科疾病:原理、进展与挑战
Advances in ophthalmology practice and research Pub Date : 2024-05-01 Epub Date: 2024-02-28 DOI: 10.1016/j.aopr.2024.02.001
Yifei Niu , Junfeng Ji , Ke Yao , Qiuli Fu
{"title":"Regenerative treatment of ophthalmic diseases with stem cells: Principles, progress, and challenges","authors":"Yifei Niu ,&nbsp;Junfeng Ji ,&nbsp;Ke Yao ,&nbsp;Qiuli Fu","doi":"10.1016/j.aopr.2024.02.001","DOIUrl":"https://doi.org/10.1016/j.aopr.2024.02.001","url":null,"abstract":"<div><h3>Background</h3><p>Degenerate eye disorders, such as glaucoma, cataracts and age-related macular degeneration (AMD), are prevalent causes of blindness and visual impairment worldwide. Other eye disorders, including limbal stem cell deficiency (LSCD), dry eye diseases (DED), and retinitis pigmentosa (RP), result in symptoms such as ocular discomfort and impaired visual function, significantly impacting quality of life. Traditional therapies are limited, primarily focus on delaying disease progression, while emerging stem cell therapy directly targets ocular tissues, aiming to restore ocular function by reconstructing ocular tissue.</p></div><div><h3>Main text</h3><p>The utilization of stem cells for the treatment of diverse degenerative ocular diseases is becoming increasingly significant, owing to the regenerative and malleable properties of stem cells and their functional cells. Currently, stem cell therapy for ophthalmopathy involves various cell types, such as embryonic stem cells (ESCs), induced pluripotent stem cells (iPSCs), mesenchymal stem cells (MSCs), and retinal progenitor cells (RPCs). In the current article, we will review the current progress regarding the utilization of stem cells for the regeneration of ocular tissue covering key eye tissues from the cornea to the retina. These therapies aim to address the loss of functional cells, restore damaged ocular tissue and or in a paracrine-mediated manner. We also provide an overview of the ocular disorders that stem cell therapy is targeting, as well as the difficulties and opportunities in this field.</p></div><div><h3>Conclusions</h3><p>Stem cells can not only promote tissue regeneration but also release exosomes to mitigate inflammation and provide neuroprotection, making stem cell therapy emerge as a promising approach for treating a wide range of eye disorders through multiple mechanisms.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 2","pages":"Pages 52-64"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S266737622400009X/pdfft?md5=05a06b3fd055e75a8b44dbdd244049e6&pid=1-s2.0-S266737622400009X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140308540","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of sentiment and word frequency analysis of physician review sites to evaluate refractive surgery care 应用医生评论网站的情感和词频分析评估屈光手术护理
Advances in ophthalmology practice and research Pub Date : 2024-05-01 Epub Date: 2024-03-07 DOI: 10.1016/j.aopr.2024.03.002
Victoria Vought , Rita Vought , Andrew S. Lee , Irene Zhou , Mansi Garneni , Steven A. Greenstein
{"title":"Application of sentiment and word frequency analysis of physician review sites to evaluate refractive surgery care","authors":"Victoria Vought ,&nbsp;Rita Vought ,&nbsp;Andrew S. Lee ,&nbsp;Irene Zhou ,&nbsp;Mansi Garneni ,&nbsp;Steven A. Greenstein","doi":"10.1016/j.aopr.2024.03.002","DOIUrl":"10.1016/j.aopr.2024.03.002","url":null,"abstract":"<div><h3>Background</h3><p>Online physician reviews increase transparency in health care, helping patients make informed decisions about their provider. Language processing techniques can quantify this data and allow providers to better understand patients' experiences, perspectives, and priorities. The objective of this study was to assess patient satisfaction and understand the aspects of care that are valued by patients seeking refractive care using sentiment and word frequency analysis.</p></div><div><h3>Methods</h3><p>Written reviews and Star ratings for members of the Refractive Surgery Alliance Society practicing in the United States were collected from Healthgrades, a popular physician rating website. Surgeons with at least one written review were included in the study. Reviews were scored from -1 (most negative) to +1 (most positive) using Valence Aware Dictionary sEntiment Reasoner (VADER). Reviews were stratified by demographic characteristics, namely gender, region, and years in practice. Word frequency analysis was applied to find the most common words and phrases.</p></div><div><h3>Results</h3><p>A total of 254 specialists and 3104 reviews were analyzed, with an average of 4.4/5 stars and mean 48 ratings each. Most physicians had positive reviews (96%, average VADER ​= ​0.69). Younger physicians (&lt;20 years since residency) had significantly higher Stars rating than senior peers (&gt;20 years) (<em>P</em> ​&lt; ​0.001). A similar trend was observed in VADER score (0.71 vs 0.69), although not statistically significant (<em>P</em> ​= ​0.06). No statistical differences were observed between Stars rating and VADER score by gender (<em>P</em> ​= ​0.66, <em>P</em> ​= ​0.83) or by geographical region (<em>P</em> ​= ​0.74, <em>P</em> ​= ​0.07). \"Staff\" (n ​= ​1269), \"professional\" (n ​= ​631), \"office\" (n ​= ​523), \"questions\" (n ​= ​424), and \"friendly\" (n ​= ​386) were frequently used in reviews, along with phrases such as \"the staff\" (n ​= ​273) and \"my questions\" (n ​= ​174). \"Surgery\" (n ​= ​719), \"staff\" (n ​= ​576), \"procedure\" (n ​= ​251), \"experience\" (n ​= ​243), and \"professional\" (n ​= ​240) were the most common words in positive reviews, while \"surgery\" (n ​= ​147), \"office\" (n ​= ​86), \"staff\" (n ​= ​54), \"time\" (n ​= ​47), and \"insurance\" (n ​= ​28) were the most commonly used in negative reviews.</p></div><div><h3>Conclusions</h3><p>Both the average Stars and VADER sentiment score suggest a high satisfaction among refractive patients. Word frequency analysis revealed that patients value non-clinical aspects of care, including interactions with staff, insurance coverage, and wait-times, suggesting that improving non-clinical factors could enhance patient satisfaction with refractive surgery.</p></div>","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 2","pages":"Pages 78-83"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000209/pdfft?md5=ea23a98b746597512a461225a39e3053&pid=1-s2.0-S2667376224000209-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140084149","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TOC 技术选择委员会
Advances in ophthalmology practice and research Pub Date : 2024-05-01 Epub Date: 2024-05-16 DOI: 10.1016/S2667-3762(24)00030-1
{"title":"TOC","authors":"","doi":"10.1016/S2667-3762(24)00030-1","DOIUrl":"https://doi.org/10.1016/S2667-3762(24)00030-1","url":null,"abstract":"","PeriodicalId":72103,"journal":{"name":"Advances in ophthalmology practice and research","volume":"4 2","pages":"Pages iii-iv"},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2667376224000301/pdfft?md5=31a31f9eba8cb7a1e864fd2bd9a6af78&pid=1-s2.0-S2667376224000301-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140949987","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书